دراسة حول إعطاء نيبوكاليماب للبالغين المصابين بالوهن العضلي الوبيل العام
This research study is looking at a new medicine called nipocalimab for adults who have a condition called generalised myasthenia gravis, or gMG. gMG causes muscles to become weak and tired easily. The main aim of the study is to find out how well nipocalimab works compared to a 'dummy' medicine (placebo) and whether it is safe to use. The study also includes a smaller part to see how the body handles nipocalimab when it's given as an injection just under the skin, compared to giving it through a drip into a vein. This helps researchers understand the best way to give the medicine. Participants will either receive the active medicine or the placebo, and their health and symptoms will be carefully monitored throughout the study.
نظرة سريعة
النتائج
نتائج هذه الدراسة
تم النشر يوليو 2025تم نشر نتائج هذه الدراسة.
ما هو موضوع هذه الدراسة؟
This research study is about a muscle weakness condition called generalised myasthenia gravis (gMG). If you have gMG, your body's immune system mistakenly attacks healthy connections between your nerves and muscles, leading to muscle weakness that can affect things like your eyes, face, throat, and limbs. This can make everyday activities quite challenging.
The study is testing a new medicine called nipocalimab. Researchers want to see if this medicine can help improve the symptoms of gMG and make a real difference to people's lives. To do this, they will compare nipocalimab to a 'dummy' treatment (called a placebo), which looks exactly like the real medicine but contains no active ingredients. This comparison helps them understand if any changes are truly due to nipocalimab or might have happened anyway.
Another important part of this study is looking at how nipocalimab works when given in different ways. Some participants will receive the medicine through a drip into a vein, which is a common way to give medicines. Others will receive it as an injection just under the skin. This helps the researchers figure out the most effective and convenient way to deliver the medicine, which could be very helpful for future patients.
النقاط الرئيسية
- This study is testing a new medicine, nipocalimab, for generalised myasthenia gravis (gMG).
- It aims to see if nipocalimab is safe and effective compared to a dummy treatment (placebo).
- The medicine might be given through a drip or as an injection under the skin.
- Participation involves regular clinic visits for treatments, tests, and symptom checks.
- You will be closely monitored, and your care team will track your health.
- You can withdraw from the study at any point without affecting your regular medical care.
من قد يكون مؤهلاً؟
To join this study, adults must have a confirmed diagnosis of generalised myasthenia gravis (gMG) that affects various muscles in their body, not just a mild form. You would need to be experiencing specific levels of muscle weakness in your daily activities according to a special scale.
The study also has some rules about other health conditions. For example, you can't have certain problems with your immune system or a history of a 'myasthenia crisis' recently. If you've had surgery to remove your thymus gland, there's a time limit for when you can join after that surgery. Also, if you know you're allergic to nipocalimab or its ingredients, you wouldn't be able to take part.
For women who could become pregnant, special pregnancy tests are required, and male participants must agree not to donate sperm during the study and for a period after. If you're considering the part of the study where the medicine is given as an injection under the skin, you'd need suitable skin on your tummy for the injections and be able to keep your regular medications for gMG stable for the first few weeks.
هل يمكن أن تناسبك هذه الدراسة؟
أجب عن هذه الأسئلة السريعة لترى ما إذا كنت مؤهلاً. هذا دليل فقط - الفريق البحثي هو الذي يتخذ القرار النهائي.
- Do I have a confirmed diagnosis of generalised myasthenia gravis (gMG)?
- Are my gMG symptoms affecting my daily activities to a certain degree?
- Have I had a thymectomy (surgery to remove my thymus gland) more than a year ago?
- Do I have any specific immune problems or allergies that might stop me from joining?
- Am I willing to attend regular clinic visits and follow the study instructions?
ماذا يتضمن المشاركة؟
If you decide to take part in this study, you'll be assigned to either receive the new medicine, nipocalimab, or a placebo (a dummy medicine). You won't know which one you're getting, and neither will your study doctor. Depending on which group you're in, the medicine could be given through a drip into a vein or as an injection under your skin. This will involve regular visits to the study clinic for these treatments and check-ups.
Throughout the study, the research team will closely monitor your health, symptoms, and how you're feeling. This will involve various tests, blood samples, and questionnaires at regular visits. These visits are important for the team to understand how the medicine is working and to make sure you are safe. For some participants, there's a specific part of the study (called a substudy) where you'll receive injections under the skin. This will also involve keeping your current gMG medications, like steroids, at a steady dose for the first 8 weeks.
The total duration of your participation in the study will involve regular visits for treatment and assessments, followed by a period where your health is still monitored even after you stop receiving the study medicine. You will be given a detailed schedule of visits and procedures if you decide to take part, and you will always have the right to withdraw from the study at any time.
المخاطر والفوائد المحتملة
Locations (112)
- Neuromuscular Research Center and Clinicالرمز البريدي المؤكدParadise Valley, United States· التوظيف
- HonorHealth Neurologyالرمز البريدي المؤكدسكوتسديل، الولايات المتحدة· مكتمل
- جامعة جنوب كاليفورنياالرمز البريدي المؤكدلوس أنجلوس، الولايات المتحدة· مكتمل
- جامعة ستانفوردالرمز البريدي المؤكدبالو ألتو، الولايات المتحدة· مكتمل
- Care Access Researchالرمز البريدي المؤكدباسادينا، الولايات المتحدة· التوظيف
- جامعة كولورادو حرم أنشوتز الطبيالرمز البريدي المؤكدأورورا، الولايات المتحدة· التوظيف
- مستشفى ييل نيو هافنالرمز البريدي المؤكدنيو هيفن، الولايات المتحدة· التوظيف
- FM Clinical Research, LLC South Florida Neurology Associates, P. A.الرمز البريدي المؤكدبوكا راتون، الولايات المتحدة· التوظيف
- University of Florida Health Jacksonvilleالرمز البريدي المؤكدجاكسونفيل، الولايات المتحدة· مكتمل
- مركز ميدسول للأبحاث السريريةالرمز البريدي المؤكدبورت شارلوت، الولايات المتحدة· التوظيف
- جامعة جنوب فلوريداالرمز البريدي المؤكدتامبا، الولايات المتحدة· التوظيف
- جامعة أوغوستاالرمز البريدي المؤكدأوغوستا، الولايات المتحدة· مكتمل
أسئلة شائعة
What is generalised myasthenia gravis (gMG)?
gMG is a condition where your body's immune system mistakenly attacks parts of your muscles, making them weak and tired easily, affecting many parts of your body.
What is nipocalimab?
Nipocalimab is a new medicine being tested to see if it can help improve the symptoms of gMG. It's not yet approved for general use.
ما هو الدواء الوهمي؟
A placebo is a 'dummy' treatment that looks like the actual medicine but doesn't contain any active ingredients. It helps researchers fairly compare the new medicine's effects.
كيف سيتم إعطاء الدواء؟
Depending on which group you're in, it could be given through a drip into your vein or as an injection just under your skin.
هل يمكنني مغادرة الدراسة إذا غيرت رأيي؟
Yes, you can choose to leave the study at any time, for any reason, without it affecting your medical care.
كيفية معرفة المزيد
جهة الاتصال للدراسة
تحدث دائمًا إلى طبيبك العام أو الأخصائي قبل اتخاذ قرار بالمشاركة في دراسة.
هل أنت مهتم بالمشاركة؟
نقاش
مناقشة المجتمع
مدعوم من منتدانا في community.patient.info. يرجى التحلي بالاحترام — هذه ليست نصيحة طبية.